Search the Site

 


BioRunUp has evolved into an informed Biotech trading community seeking to generate consistent profits (in any market condition) through a variety of long, short and options based strategies.


Take a look at our recent verified profits of over $500,000
Mark Messier
Mike Havrilla

Join Our FREE Mailing List and Receive the eBook
"Five Tips to Better Biotech Trading / 
Understanding the BioCatalyst Process"
Some of the features of BioRunUp.com include:
- Detailed Reports on Upcoming FDA and Clinical Trial Trades
- REAL TIME Posting of Trades (Entries and Exits)
- Clinical and Regualtory Catalyst Database with over 300 events and updated daily 
- Members Only Live Interactive Webinars 
- Live Chat Room 
- Video Lessons / Trade Reviews
- Chart / Technical Analysis 
- Run-Up Valuation Studies
- Weekly Watchlist Newsletter
- Email / SMS (Text Message) Alerts of critical news
- Access to view Mark Messier and Mike Havrilla's Trading Accounts
- A More Detailed FDA Calendar
- Historical FDA Tracker
- Bio-Pharma, FDA, Clinical Trials, and Stock Market News Updates
- Direct Email Communication
- Affiliate Program

The cost for an annual subscription is $697 and includes all the above features. We also offer a monthly plan for $99.95. 


Take a look at excerpts from BioRunUp subscriber testimonials:
"My most recent and profitable trade are the EXAS Oct $5 options which I purchased at $.40 off of BioRunUp blog alert. They are currently yielding a 700% return!!!"

"Within 1 month my brand new porfolio was up over 23%!"

"I started the biorunup method on Aug. 9th 2010 and before the end of Sept. I was up 35%."

"In the first month I made a 13% return, doubling the return of the market as a whole - without leverage. To date, I have never failed to beat the market when applying the methods outlined in the pages of BioRunUp."

"
I don’t ever take recommendations from people on the Internet, but this one looked right, felt right and sounded right.  Thanks BioRunUp, you made me a fortune."

 

Recent articles

 

BioRunUp Webinar - Thursday 6/20/13 4:30pm EST

(in: Articles)
 

Technical Tuesday Video 6/18/13 $AMRN $ATRS $BIOD $APPA $OPK

(in: Articles)
 

6/17/13 Catalyst Summary

(in: Articles)
 

$ANTH Well-Funded for Potential Long-Term Turnaround Play

(in: Articles)
 

This Week's Watchlist 06/17/13

(in: Articles)
 

6/13/13 Catalyst Calendar Summary

(in: Articles)
 

NOTICE- BioRunUp Webinar Date Change

(in: Articles)
 

Technical Tuesday Video - 6/11/13 $BIOD $FOLD $APPY $AMRN $BDSI $BLRX $HALO

(in: Articles)
 

$CHTP Plans Mid-Year NDA Resubmission for Northera

(in: Articles)
 

This Week's Watchlist 6/10/13

(in: Articles)
 

$ECTE Diabetes Care Developer w/ Pivotal CE Mark Clinical Catalyst

(in: Articles)
 

Technical Tuesday Video 6/4/13 $RMTI $APPY $ATRS $XNPT $LCI

(in: Articles)
 

$ANAC A Variety of Catalysts Pending During 2H13

(in: Articles)
 

This Week's Watchlist 6/3/13

(in: Articles)
 

$ABIO Closes $20M Offering to Fund Phase 2b/3 Clinical Trial

(in: Articles)
 

New Trade for Mike with Pair of Phase 2 Catalysts & Big Pharma Partner

(in: Articles)
 

$AMRN Aims to Expand FDA Label, Grow Sales of VASCEPA

(in: Articles)
 

BioRunUp Webinar - Thursday 5/30/13 4:30pm EST

(in: Articles)
 

$SRPT Key FDA Catalyst Expected During 3Q13

(in: Articles)
 

This Week's Watchlist 5/28/13

(in: Articles)